Company intelligence / Profile preview

206 Ortho

Lowell, Massachusetts, United States206ortho.com ↗

Ownership: Private
Development stage: Preclinical

Overview

206 Ortho has developed a patented, bioresorbable high-strength composite material designed to replace permanent metal implants in orthopedic surgery. The technology aims to provide temporary support for bone healing and then fully resorbs, eliminating the need for secondary surgeries to remove hardware. Early results suggest potential to reduce pain, improve outcomes, and lower healthcare costs associated with implant removal[3][4][5].

Therapeutic areas: OtherRheumatology
Modalities: DeviceBiologic (bioresorbable composite implant)
Industry: Implantable Medical Devices

Partnerships

Smith & Nephew (collaboration at M2D2 incubator)

Beyond the preview

Go deeper on 206 Ortho.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 206 Ortho.

Explore the full profile